(Q41579450)

English

Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer.

scientific article published on 28 January 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

title

Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

author name string

Angela M H Brodie

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

language of work or name

English

0 references

publication date

28 January 2015

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

published in

Journal of Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

volume

58

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

page(s)

2077-2087

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

Identifiers

DOI

10.1021/JM501239F

1 reference

stated in

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

Europe PubMed Central

PubMed ID

25591066

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25591066%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 February 2020

ResearchGate publication ID

270963902

0 references

(Q41579450)

Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)